Skip to main content
Porto

PMMNG logo

  • Home
  • News
  • Our Meetings
    • Monthly PMMNG Meetings
    • Steering Committee Meetings
  • Myeloma Events
    • Upcoming Events
    • Archived Myeloma Events
  • Our Members
  • Miles for Myeloma
  • Resources
    • Myeloma Education Resources
    • Myeloma and Cancer Foundations
    • Regional Myeloma Support Groups
    • Publications and Newsletters
    • Cancer Support Networks
    • Treatments
    • Financial Assistance
    • Caregivers
  • Clinical Trials

Archived Events
  • CancerCare: Current Perspectives on Cancer Survivorship
  • MMRF: Patient Summit – Virtual Web Conference
  • Myeloma Crowd: Multiple Myeloma Care in 2021
  • IMF: Best of ASH 2020
  • MMRF: Expert Session on Smoldering Myeloma
  • MMRF: Multiple Myeloma Highlights From the 2020 American Society of Hematology (ASH) Meeting & Exposition
  • Myeloma Crowd: The IMPACT of COVID-19 on MGUS, Smoldering Myeloma, African Americans and Myeloma Patient Family Members
  • CancerCare: Updates from the 2020 American Society of Hematology (ASH) Annual Meeting
  • IMF: IMWG Conference Series - ASH 2020
  • CancerCare: How Diagnostic Technologies and Biomarkers Improve Treatment Decisions for People Living with Cancer

CancerCare: Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation - New Treatment Approaches

CancerCare logoWhat: Webcast audio (60:00)
When: Thursday, April 30, 2020, 1:30 – 2:30 PM ET
Where: Web
Listen to Webcast Audio

Tags
event
archived
webcast
cancercare
bone marrow transplant
allogeneic stem cell transplant
graft vs host disease
gvhd
treatment
clinical trials
Dr. Markus Y. Mapara
Dr. Samer Al-Homsi
Dr. Yi-Bin Chen
Paige Soleimani